Open AccessSecukinumab's Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment
Author(s) -
P. van de Kerkhof,
Kristian Reich,
C Leonardi,
Andrew Blauvelt,
NN Mehta,
TF Tsai,
Ruquan You,
Phil Papanastasiou,
M. Milutinovic,
Cem Griffiths
Publication year - 2018
Publication title -
skin
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.18
Subject(s) - secukinumab , medicine , term (time) , psoriasis , clinical trial , safety profile , pooled analysis , dermatology , meta analysis , adverse effect , psoriatic arthritis , physics , quantum mechanics
Abstract not available. Disclosures: Study sponsored by Novartis. Copyright 2018 SKIN